Reporting Medicare fraud brings $18.1M reward

  Reporting Medicare fraud paid off for hospital administrator Randi Ferrare, who will get a $1.8 million Medicare fraud reward.  The reward is her share of the $10.1 million government settlement with Morton Plan Health System. Ferrare brought a Medicare Whistleblower suit under the Federal False Claims Act, alleging that the Florida hospital system over-billed Medicare.  Hospitals affiliated with Morton Plant Health Care billed certain cardiac procedures as inpatient care, when it should have been billed on a lower cost outpatient basis. The rates Medicare pays for inpatient care...

read more

Medicare fraud doctor recruited patients with fast food

A $5.4 million Medicare fraud scheme lands gynecologist Jonathan Agbebiyi in prison.  Agbebiyi was sentenced to 60 months in prison and ordered to pay nearly $3 million in restitution. He was a part of a conspiracy to bill Medicare for unnecessary neurological tests at three Michigan clinics.  Some of the unnecessary tests included sending an electrical current through the arms and legs of the patients. Explains the U.S. Department of Justice: Evidence at trial showed that the patients were not referred to the clinics by their primary care physicians, or for any other legitimate purpose,...

read more

Medicare Whistleblower Pharmacy Receives Millions

A Medicare whistleblower pharmacy in Florida is leading the way in reporting Medicare fraud.  After numerous successful False Claims Act cases, Ven-a-care pharmacy is making millions in Medicare fraud rewards. Reporting Medicare Fraud in Florida A special report from Florida Trend details how the small pharmacy has become one of the most successful Medicare whistleblowers in the country.  Ven-a-care is responsible for exposing billions in over-charges to Medicare and Medicaid for prescription drugs. Explains the report: In August 2011, Attorney General Pam Bondi filed a three-paragraph...

read more

$17M Off-Label Marketing Whistleblower Reward

A whistleblower in an off-label marketing case against Boehringer Ingelheim Pharmaceuticals Inc. will receive more than $17 million as a reward.  The reward is his share of a $95 million settlement with the government.  Whistleblowers get a share of such settlements as a reward for reporting fraud under the False Claims Act. Robert Heiden, a former sales representative for Boehringer, blew the whistle on the company’s illegal off-label marketing of three different drugs.  The three drugs were Aggrenox, Combivent, and Micardis. The government alleged that Boehreinger marketed these...

read more

Facebook